©
Nuffield Department of Surgical Sciences
Led by Professor Clare Verrill at the University of Oxford’s Nuffield Department of Surgical Sciences, the study is one of the first examples of real time use of AI technology in NHS histopathology practice. It provides new evidence that AI can be safely and effectively incorporated within routine diagnostic workflows.
The technology, Paige Prostate, was evaluated in the prostate cancer biopsy pathway across three NHS trusts in the UK. The aim was to assess whether the AI diagnostic system could support more consistent and accurate diagnosis.
The Paige Prostate Suite is a group of AI-powered applications designed to aid in the detection and grading of prostate cancer on routine stained images of prostate needle biopsies. The study examined how using the Paige Prostate Suite impacted pathologists’ clinical decision-making, pathology service delivery, and use of resources in real-world NHS setting.
The study - called ‘Articulate Pro: Artificial Intelligence for Cellular Pathology Transformation in Prostate Practice’ - was delivered by a multi-disciplinary team, and the technology was rolled out for evaluation at Oxford University Hospitals NHS Foundation Trust, North Bristol NHS Trust, and University Hospitals Coventry and Warwickshire NHS Trust.